Aker BioMarine is pleased to invite investors, analysts and media to its Capital Markets Update on Thursday 1 December at 09:00 (CET). The event will be webcasted at www.akerbiomarine.com.
Program:
09:00 (CET): Presentations by executive management in Aker BioMarine
Approx. 10:20 (CET): Q&A conference call
The accompanying presentation material for the Capital Markets Update will be published around 07:00 (CET) the same day.
To participate in the Q&A conference call, please contact the conference call operator at the telephone numbers listed below. Please join the event prior to scheduled start time and provide the confirmation code or ask for Aker BioMarine's Capital Markets Update.
Phone number Norway: +47 2350 2007
Phone number International: +44 (0) 330 336 9125
Confirmation code: 1155264
The presentations and Q&A conference call will be webcasted at www.akerbiomarine.com.
For further information, please contact:
Carl Christian Bachke, Investor Relations
Mobile: +47 909 808 48
Email: carl.bachke@akerbiomarine.com
About Aker BioMarine ASA
Aker BioMarine is a leading biotech innovator and Antarctic krill-harvesting company developing krill-derived products for pharma, consumer health and wellness as well as animal nutrition. The company has a strong position in its industry and is the world's leading supplier of krill, the natural, powerful and health promoting source of nutrients from the pristine waters of Antarctica. Aker BioMarine is listed on Oslo Stock Exchange (AKBM). More information is available at www.akerbiomarine.com.
This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act.